When did DENTSPLY SIRONA report Q3 2025 earnings?

DENTSPLY SIRONA (XRAY) reported Q3 2025 earnings on November 6, 2025 before market open.

What were DENTSPLY SIRONA's Q3 2025 revenue and EPS?

DENTSPLY SIRONA reported revenue of $904.0M and eps of $0.37 for Q3 2025.

Did DENTSPLY SIRONA beat estimates in Q3 2025?

Revenue missed the consensus estimate of $927.1M by $23.1M. EPS missed the consensus estimate of $0.45 by $0.08.

How did DENTSPLY SIRONA's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 4.9% from $951.0M a year earlier and eps declined 26.0% from $0.50.

Where can I find DENTSPLY SIRONA's Q3 2025 SEC filings?

You can read the 8-K earnings release (0000818479-25-000254) and the 10-Q periodic report (0000818479-25-000257) directly on SEC EDGAR. The filing index links above go to sec.gov.

DENTSPLY SIRONA XRAY Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$904.0MMiss by $23.1M

EPS$0.37Miss by $0.08

Revenue estimate$927.1M

EPS estimate$0.45

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$889.1M

EPS estimate$0.36

Financials

Q3 2025

Income statement

See full

Revenue$904.0M-4.9%

Gross profit$441.0M-10.9%

Operating income-$218.0M+52.8%

Net income-$427.0M+13.6%

EPS (diluted)-$2.14+13.0%

Balance sheet

See full

Cash & equivalents$363.0M+22.6%

Total debt$2.5B+6.9%

Total equity$1.5B-40.7%

Total assets$5.7B-14.7%

Cash flow

See full

Operating cash flow$79.0M-44.0%

CapEx$39.0M-9.3%

Free cash flow$40.0M-59.2%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$2.53B-54.5%

Enterprise value$4.65B-38.7%

P/S0.7×-0.7×

Profitability

See full

Gross margin50.9%-1.3pp

Operating margin-21.9%—

Net margin-24.3%—

FCF margin2.2%-7.2pp

Returns & leverage

See full

Return on equity-44.4%—

Debt / equity1.7×+0.7×

Current ratio1.5×+0.2×

Segments

By segment

See full

Essential Dental Solutions$357.0M-3.3%

Connected Technology Solutions$259.0M-3.7%

Orthodontic and Implant Solutions$205.0M-14.9%

Wellspect Healthcare$83.0M+15.3%

By product

See full

Implants & Prosthetics$152.0M-3.8%

Equipment & Instruments$148.0M+7.2%

CAD/CAM$111.0M-15.3%

Orthodontics$53.0M-36.1%

Versus estimates

Revenue

Q1 2026$880.0MBeat by $38.2M Q4 2025$961.0MBeat by $34.8M

Q3 2025$904.0MMiss by $23.1M

Q2 2025$936.0MBeat by $31.4M Q1 2025$879.0MMiss by $41.2M Q4 2024$905.0MBeat by $3.7M

Diluted EPS

Q1 2026$0.27Miss by $0.01 Q4 2025$0.27Miss by $0.01

Q3 2025$0.37Miss by $0.08

Q2 2025$0.52Beat by $0.02 Q1 2025$0.43Beat by $0.14 Q4 2024$0.26Miss by $0.21

Ask the moment DENTSPLY SIRONA reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did DENTSPLY SIRONA report Q3 2025 earnings?: DENTSPLY SIRONA (XRAY) reported Q3 2025 earnings on November 6, 2025 before market open.
What were DENTSPLY SIRONA's Q3 2025 revenue and EPS?: DENTSPLY SIRONA reported revenue of $904.0M and eps of $0.37 for Q3 2025.
Did DENTSPLY SIRONA beat estimates in Q3 2025?: Revenue missed the consensus estimate of $927.1M by $23.1M. EPS missed the consensus estimate of $0.45 by $0.08.
How did DENTSPLY SIRONA's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 4.9% from $951.0M a year earlier and eps declined 26.0% from $0.50.
Where can I find DENTSPLY SIRONA's Q3 2025 SEC filings?: You can read the 8-K earnings release (0000818479-25-000254) and the 10-Q periodic report (0000818479-25-000257) directly on SEC EDGAR. The filing index links above go to sec.gov.